rdf:type |
|
lifeskim:mentions |
umls-concept:C0013058,
umls-concept:C0013227,
umls-concept:C0031336,
umls-concept:C0034866,
umls-concept:C0162458,
umls-concept:C0238711,
umls-concept:C0444454,
umls-concept:C0814225,
umls-concept:C0936012,
umls-concept:C1519193,
umls-concept:C1553890
|
pubmed:issue |
4
|
pubmed:dateCreated |
2006-8-14
|
pubmed:abstractText |
Timely access to necessary medicines that Australians need is one of the four pillars of the Australian Government's National Medicines Policy. We were interested to determine whether there was a change in the time taken for medicines to be listed once recommended by the Pharmaceutical Benefits Advisory Committee (PBAC).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1098-3015
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
9
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
205-12
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:16903989-Advisory Committees,
pubmed-meshheading:16903989-Australia,
pubmed-meshheading:16903989-Cost-Benefit Analysis,
pubmed-meshheading:16903989-Decision Making, Organizational,
pubmed-meshheading:16903989-Drug Prescriptions,
pubmed-meshheading:16903989-Formularies as Topic,
pubmed-meshheading:16903989-Health Policy,
pubmed-meshheading:16903989-Health Services Accessibility,
pubmed-meshheading:16903989-Humans,
pubmed-meshheading:16903989-Insurance, Pharmaceutical Services,
pubmed-meshheading:16903989-Linear Models,
pubmed-meshheading:16903989-Time
|
pubmed:articleTitle |
Are Australians able to access new medicines on the pharmaceutical benefits scheme in a more or less timely manner? An analysis of pharmaceutical benefits advisory committee recommendations, 1999-2003.
|
pubmed:affiliation |
Novartis Pharmaceuticals Australia Pty Ltd, North Ryde, NSW, Australia. michael.wonder@novartis.com
|
pubmed:publicationType |
Journal Article
|